Giovanni Palazzolo

1.0k total citations
47 papers, 786 citations indexed

About

Giovanni Palazzolo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Giovanni Palazzolo has authored 47 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 33 papers in Pulmonary and Respiratory Medicine and 15 papers in Molecular Biology. Recurrent topics in Giovanni Palazzolo's work include Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Research Studies (31 papers) and Cancer therapeutics and mechanisms (11 papers). Giovanni Palazzolo is often cited by papers focused on Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Research Studies (31 papers) and Cancer therapeutics and mechanisms (11 papers). Giovanni Palazzolo collaborates with scholars based in Italy, United States and Sweden. Giovanni Palazzolo's co-authors include Cesare Gridelli, Antônio Rossi, Paolo Maione, Francesca Casaluce, Paola Claudia Sacco, Assunta Sgambato, Fortunato Ciardiello, Marianna Ferrara, Ciro Gallo and Carmine Ferrara and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Giovanni Palazzolo

46 papers receiving 762 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giovanni Palazzolo Italy 15 528 474 211 85 83 47 786
Caicun Zhou China 12 435 0.8× 393 0.8× 197 0.9× 106 1.2× 82 1.0× 36 710
Fernando C. Santini United States 13 685 1.3× 464 1.0× 211 1.0× 143 1.7× 115 1.4× 34 958
Ruqin Chen United States 11 511 1.0× 559 1.2× 161 0.8× 88 1.0× 39 0.5× 22 764
J.M. Sánchez-Torres Spain 13 614 1.2× 428 0.9× 150 0.7× 104 1.2× 99 1.2× 21 772
Charles Ricordel France 14 467 0.9× 529 1.1× 198 0.9× 81 1.0× 36 0.4× 74 787
Sally C. M. Lau Canada 13 333 0.6× 281 0.6× 124 0.6× 80 0.9× 45 0.5× 37 529
Monica Giovannini Italy 14 473 0.9× 414 0.9× 204 1.0× 151 1.8× 35 0.4× 35 744
Kiichiro Ninomiya Japan 16 512 1.0× 474 1.0× 138 0.7× 67 0.8× 54 0.7× 81 715
Luckson Mathieu United States 8 290 0.5× 254 0.5× 157 0.7× 75 0.9× 40 0.5× 12 526
Georgia Gomatou Greece 11 260 0.5× 270 0.6× 161 0.8× 75 0.9× 47 0.6× 33 522

Countries citing papers authored by Giovanni Palazzolo

Since Specialization
Citations

This map shows the geographic impact of Giovanni Palazzolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giovanni Palazzolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giovanni Palazzolo more than expected).

Fields of papers citing papers by Giovanni Palazzolo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giovanni Palazzolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giovanni Palazzolo. The network helps show where Giovanni Palazzolo may publish in the future.

Co-authorship network of co-authors of Giovanni Palazzolo

This figure shows the co-authorship network connecting the top 25 collaborators of Giovanni Palazzolo. A scholar is included among the top collaborators of Giovanni Palazzolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giovanni Palazzolo. Giovanni Palazzolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sacco, Paola Claudia, Paolo Maione, Giovanni Palazzolo, & Cesare Gridelli. (2018). Treatment of advanced non-small cell lung cancer in the elderly. Expert Review of Respiratory Medicine. 12(9). 783–792. 13 indexed citations
3.
Santabarbara, Giuseppe, Paolo Maione, Antônio Rossi, Giovanni Palazzolo, & Cesare Gridelli. (2016). The role of pembrolizumab in the treatment of advanced non-small cell lung cancer. Annals of Translational Medicine. 4(11). 215–215. 10 indexed citations
4.
Rossi, Antônio, Paola Claudia Sacco, Assunta Sgambato, et al.. (2016). Optimal drugs for second-line treatment of patients with small-cell lung cancer. Expert Opinion on Pharmacotherapy. 17(7). 969–976. 13 indexed citations
5.
Sacco, Paola Claudia, Paolo Maione, Antônio Rossi, et al.. (2015). Necitumumab for the treatment of stage IV metastatic squamous non-small-cell lung cancer. Expert Review of Respiratory Medicine. 9(3). 245–254. 3 indexed citations
6.
Maione, Paolo, Antônio Rossi, Assunta Sgambato, et al.. (2015). New Antiangiogenetic Therapy Beyond Bevacizumab in the Treatment of Advanced Non Small Cell Lung Cancer. Current Pharmaceutical Design. 21(32). 4763–4772. 4 indexed citations
7.
Casaluce, Francesca, Assunta Sgambato, Paola Claudia Sacco, et al.. (2014). Emerging drugs targeting PD-1 and PD-L1: reality or hope?. Expert Opinion on Emerging Drugs. 19(4). 557–569. 10 indexed citations
8.
Sgambato, Alessandro, Francesca Casaluce, Antônio Rossi, et al.. (2012). The Role of EGFR Tyrosine Kinase Inhibitors in the First-Line Treatment of Advanced Non Small Cell Lung Cancer Patients Harboring EGFR Mutation. Current Medicinal Chemistry. 19(20). 3337–3352. 33 indexed citations
9.
Gridelli, Cesare, Antônio Rossi, Paolo Maione, et al.. (2011). Non-small cell lung cancer therapy in the elderly.. PubMed. 9(5). 375–83. 1 indexed citations
10.
Rossi, Antônio, Paolo Maione, Clorinda Schettino, et al.. (2011). Non-small-cell lung carcinoma vaccines in clinical trials. Expert Review of Vaccines. 10(6). 887–897. 5 indexed citations
11.
Sacco, Paola Claudia, Paolo Maione, Antônio Rossi, et al.. (2011). Combination of radiotherapy and targeted therapies in the treatment of locally advanced non-small cell lung cancer. Targeted Oncology. 6(3). 171–180. 10 indexed citations
12.
Schettino, Clorinda, Maria Anna Bareschino, Antônio Rossi, et al.. (2009). Review: The potential role of bevacizumab in early stages and locally advanced non-small cell lung cancer. Therapeutic Advances in Medical Oncology. 1(1). 5–13. 4 indexed citations
13.
Rossi, Antônio, Paolo Maione, Giuseppe Colantuoni, et al.. (2009). Recent Developments of Targeted Therapies in the Treatment of Non-Small Cell Lung Cancer. Current Drug Discovery Technologies. 6(2). 91–102. 22 indexed citations
14.
Gridelli, Cesare, et al.. (2009). Treatment of advanced non-small-cell lung cancer in the elderly. Lung Cancer. 66(3). 282–286. 23 indexed citations
15.
Gridelli, Cesare, Ciro Gallo, Massimo Di Maïo, et al.. (2004). A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study. British Journal of Cancer. 91(12). 1996–2004. 143 indexed citations
16.
Gridelli, Cesare, Francesco Perrone, Giovanni Pietro Ianniello, et al.. (1998). Carboplatin plus vinorelbine, a new well-tolerated and active regimen for the treatment of extensive-stage small-cell lung cancer: a phase II study. Gruppo Oncologico Centro-Sud-Isole.. Journal of Clinical Oncology. 16(4). 1414–1419. 22 indexed citations
17.
Carbone, Ennio, Giuseppe Terrazzano, Marco Colonna, et al.. (1996). Natural killer clones recognize specific soluble HLA class I molecules. European Journal of Immunology. 26(3). 683–689. 38 indexed citations
18.
Gridelli, Cesare, S. Palmeri, Modesto DʼAprile, et al.. (1996). Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. Annals of Oncology. 7(8). 821–826. 32 indexed citations
19.
Gridelli, Cesare, Sabino De Placido, Pasquale Incoronato, et al.. (1993). Phase I study of epirubicin plus vinorelbine with or without G-CSF in advanced non-small cell lung cancer. European Journal of Cancer. 29(12). 1729–1731. 13 indexed citations
20.
Gridelli, Cesare, et al.. (1992). Mitomycin C plus vindesine or cisplatin plus epirubicin in previously treated patients with symptomatic advanced non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 30(3). 212–214. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caicun Zhou Breakdown of academic impact, for papers by Fernando C. Santini Breakdown of academic impact, for papers by Ruqin Chen Breakdown of academic impact, for papers by J.M. Sánchez-Torres Breakdown of academic impact, for papers by Charles Ricordel Breakdown of academic impact, for papers by Sally C. M. Lau Breakdown of academic impact, for papers by Monica Giovannini Breakdown of academic impact, for papers by Kiichiro Ninomiya Breakdown of academic impact, for papers by Luckson Mathieu Breakdown of academic impact, for papers by Georgia Gomatou
Rankless by CCL
2026